Autopsy report · NCT01355562

Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Primary Investigator is no longer employed at LLU as of 02/29/12.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: Loma Linda University
Sponsor type: University, hospital or other
Conditions: Melanoma; Metastatic Kidney Cancer
Interventions: Interleukin-2 (IL-2)
Participants: 0
Sites: 2
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.